Clinical trial
Atrial Deganglionation as a Therapy for Cardiac Surgery Patients With Atrial Fibrillation
NCT05426759 is registered in ClinicalTrials.gov with Atrian Medical Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Atrial Deganglionation as a Therapy for Cardiac Surgery Patients With Atrial Fibrillation
- Lead sponsor
- Atrian Medical Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 1, 2022
- Completion date
- June 30, 2023
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.